Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal insulin pretreatment for prevention of postoperative delirium after knee replacement at high altitude
ChiCTR2500107937Phase 4Not yet recruiting
- Sponsor
- Ganzi Tibetan Autonomous Prefecture People's Hospital
- Start
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of human insulin in postoperative delirium (POD) (2 arms), sponsored by Ganzi Tibetan Autonomous Prefecture People's Hospital. Primary endpoint: Incidence of postoperative delirium (POD). Planned start Aug 2025; status: not yet recruiting.
02
Drugs
human insulin
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2500107937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107937.